Stay updated with breaking news from Developmental Biology Programme. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Drugs which are commonly-used as the first line of treatment for colorectal cancer cause the tumor cells to oversecrete proteins known as mucins, according to a new study published today in the journal eLife.
Drugs that are commonly used as the first line of treatment for colorectal cancer can cause cancer cells to oversecrete proteins known as mucins. The proteins form a physical barrier that prevents drugs from reaching their target.
Drugs which are commonly-used as the first line of treatment for colorectal cancer cause the tumour cells to oversecrete proteins known as mucins
Get latest articles and stories on Health at LatestLY. Colorectal cancer occurs when tumours develop in the colon or rectum. Adenocarcinomas are the most common type of colorectal cancer, often growing from the cells that constitute the mucous lining of the tissue. A new study has said that drugs that are commonly used as the first line of treatment for colorectal cancer cause the tumour cells to oversecrete proteins known as mucins. Health News | Colorectal Cancers Raise Defensive Barrier in Response to Chemotherapy: Study.